HomeCompareTNABF vs JNJ

TNABF vs JNJ: Dividend Comparison 2026

TNABF yields 3.80% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $9.8K in total portfolio value· pulled ahead in Year 6
10 years
TNABF
TNABF
● Live price
3.80%
Share price
$3.40
Annual div
$0.13
5Y div CAGR
-44.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.5K
Annual income
$1.10
Full TNABF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — TNABF vs JNJ

📍 JNJ pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTNABFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TNABF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TNABF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TNABF
Annual income on $10K today (after 15% tax)
$323.00/yr
After 10yr DRIP, annual income (after tax)
$0.94/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,985.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TNABF + JNJ for your $10,000?

TNABF: 50%JNJ: 50%
100% JNJ50/50100% TNABF
Portfolio after 10yr
$25.4K
Annual income
$2,345.25/yr
Blended yield
9.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TNABF
No analyst data
Altman Z
1.1
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TNABF buys
0
JNJ buys
0
No recent congressional trades found for TNABF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTNABFJNJ
Forward yield3.80%2.13%
Annual dividend / share$0.13$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-44.5%28%
Portfolio after 10y$20.5K$30.3K
Annual income after 10y$1.10$4,689.40
Total dividends collected$480.00$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TNABF vs JNJ ($10,000, DRIP)

YearTNABF PortfolioTNABF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,911$210.90$10,592$272.30+$319.00TNABF
2$11,794$119.36$11,289$357.73+$505.00TNABF
3$12,687$66.92$12,123$472.89+$564.00TNABF
4$13,612$37.34$13,141$629.86+$471.00TNABF
5$14,586$20.78$14,408$846.81+$178.00TNABF
6← crossover$15,618$11.55$16,021$1,151.60$403.00JNJ
7$16,718$6.41$18,122$1,588.22$1.4KJNJ
8$17,892$3.56$20,930$2,228.20$3.0KJNJ
9$19,146$1.98$24,792$3,191.91$5.6KJNJ
10$20,487$1.10$30,274$4,689.40$9.8KJNJ

TNABF vs JNJ: Complete Analysis 2026

TNABFStock

Tenaga Nasional Berhad engages in the generation, transmission, distribution, and sale of electricity in Malaysia and internationally. The company operates and maintains thermal generation facilities and hydroelectric power generating schemes, as well as supports independent power producers; and manages and operates the National Grid that is connected to Thailand's transmission system, as well as Singapore's transmission system at Senoko. It also supplies fuel and coal for power generation; generates, distributes, supplies, deals in, and sells various energy sources, as well as provides related technical services; develops district cooling systems; operates and maintains co-generation works; manufactures, sells, and repairs distribution, power, and earthing transformers; and develops, owns, and manages dry bulk terminals. In addition, the company provides turnkey contracting of transmission substations; repair and maintenance services to heavy industries and other related services; operation and maintenance services on telecommunication equipment and data centres; higher education, and telecommunication and IT infrastructure solution and services; research and development services in the areas of engineering, information technology, business, accountancy, and liberal studies; and training courses. Further, it offers insurance and reinsurance products, parking facilities for motor vehicles, technical and laboratory, and consultancy and other services; manufactures and distributes power and general cables, and aluminum rods; operates an integrated district cooling systems for air conditioning systems of office buildings; assembles, manufactures, tests, reconditions, and distributes high and medium voltage switchgears, and control gears for transmission and distribution of electric power; and operates wind assets. It primarily serves commercial, industrial, and residential customers. The company was founded in 1949 and is headquartered in Kuala Lumpur, Malaysia.

Full TNABF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this TNABF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TNABF vs SCHDTNABF vs JEPITNABF vs OTNABF vs KOTNABF vs MAINTNABF vs ABBVTNABF vs MRKTNABF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.